PPA
RLAY icon

Parametric Portfolio Associates’s Relay Therapeutics RLAY Stock Holding History

Parametric Portfolio Associates’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.25M Buy
75,283
+35,040
+87% +$850K ﹤0.01% 2359
2021
Q4 		$1.24M Sell
40,243
-2,740
-6% -$86.6K ﹤0.01% 2695
2021
Q3 		$1.35M Buy
42,983
+4,241
+11% +$143K ﹤0.01% 2661
2021
Q2 		$1.42M Buy
38,742
+8,923
+30% +$294K ﹤0.01% 2615
2021
Q1 		$1.03M Buy
29,819
+8,272
+38% +$359K ﹤0.01% 3152
2020
Q4 		$895K Buy
21,547
+6,868
+47% +$310K ﹤0.01% 3102
2020
Q3 		$625K Buy
+14,679
New +$560K ﹤0.01% 3162

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return